WORLDWIDE‑CORRUPTION

United States · U.S. Securities and Exchange Commission (FCPA) · SEC FCPA enforcement action resolved

SciClone Pharmaceuticals

Why it is here

U.S. Securities and Exchange Commission (FCPA) — SEC FCPA enforcement action resolved (Foreign Corrupt Practices Act charges), from 4 February 2016.

Enforcement action of the U.S. Securities and Exchange Commission under the Foreign Corrupt Practices Act, resolved against the company.

Details

Company
SciClone Pharmaceuticals
Authority
U.S. Securities and Exchange Commission (FCPA)
Decision
SEC FCPA enforcement action resolved
Grounds and details, as published
Foreign Corrupt Practices Act charges
From
4 February 2016
Until
—
Status
End date not published
Source
https://www.sec.gov/enforcement-litigation/fcpa/fcpa-cases
Licence
Public domain (U.S. Government work)

SourceJSONU.S. Securities and Exchange Commission (FCPA) · SEC FCPA enforcement action resolved